Ningbo Huize Commodity

(Image: Getty/Milkos)

FDA makes example out of Chinese OTC manufacturer

By Ben Hargreaves

The FDA posted a public missive alongside a warning letter to a Chinese OTC drug manufacturer, highlighting the efforts it had been making to address data integrity issues.